American Beacon Advisors, Inc. Gilead Sciences, Inc. Transaction History

American Beacon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $263,106 - $343,334	-4,346 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $63,724 - $70,554	894 Added 25.9%	4,346 $336,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $50,671 - $59,106	781 Added 29.24%	3,452 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $98,044 - $115,090	1,378 Added 106.57%	2,671 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,293	1,293 $91.5 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of American Beacon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on American Beacon Advisors, Inc. with notifications on news.